The pharmaceutical industry could generate more than $1.2 trillion in global sales in 2025, according to Statista. The cancer segment alone is expected to generate $208 billion in sales this year. The ...

Anti-IL-4Rα monoclonal antibodies are among the best-selling biologics in this field. MG-K10 is an innovative long-acting anti-IL-4Rα humanizedmonoclonal antibody that simultaneously blocks the ...

Stuffy, sneezing, miserable: folks plagued by chronic sinusitis know the feeling all too well. Experts at University of Cincinnati Health say it's also an all-too-common affliction, affecting an ...

They create a protective barrier that keeps the area clean and prevents picking. The best acne spot treatment comes with patches in two sizes to accommodate different blemish sizes. I slap these ...

Rotorua's Wai Ariki Hot Springs & Spa boasts a variety of geothermal pools alongside a suite of bespoke spa treatments to help ... these are the best spots to indulge in a little self-care in ...

They also compared each treatment to one of three types of controls: pill placebo, waitlist or behavioral control. ERP, which is a form of cognitive behavioral therapy, performed the best ...

Creating a roundup of the 25 best-selling books of all time is harder than it sounds. Books—especially those published hundreds of years ago—were published in different editions and translated ...

While over-the-counter treatments ... growths in the nasal passages or sinuses can obstruct airflow, causing chronic congestion and loss of smell. Surgical removal of these polyps improves ...

as an add-on treatment with intranasal corticosteroids to treat chronic rhinosinusitis with nasal polyps (CRSwNP) in the adult population. This marks the third indication for an interleukin-5 (IL ...

a chronic condition for which new and effective treatments are needed. Patients now have a non-surgical option available to them and an alternative to repeated exposure to oral corticosteroids.” It is ...

GSK plc announced that the China National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with ...

Dr. Celedón mentioned that there is a better treatment for the T2-high disease because research has progressed quickly with this variant. However, the nasal swab research has made way for the T17 ...